TC Biopharm
TC Biopharm are leading the way in the future treatment of cancer and infectious diseases as pioneers of the first scalable "off the shelf" allogeneic gamma delta T cell therapy platform. They are developing safer, efficacious, cost-effective cell therapy products which can target more cancers and infectious disease and save more lives.
Did you know that female investors are more likely to invest in female-founded companies? And did you know that according to UKBAA research, only 14% of investors are women? That’s why there really is no better time to join us and become an Investing Women Angel 🧵👇
We are actively turning the dial for women-led businesses and for women in investment. As a group, we’re quietly and determinedly driving meaningful change, through training, collaboration, and most importantly - investment 🤝
And what’s more, we’re always happy to welcome new members who are interested in investing in early-stage companies, particularly those led by female founders. Find out more on our website 🔽
https://www.investingwomen.co.uk/join/
Today our sister organisation kicked off delivery of the Female Founders Accelerator, powered by Barclays Eagle Labs, funded by UK Government.
Our Angels will also be taking part, offering mentoring services to founders throughout the programme. We look forward to taking part!
Wishing you and your loved ones a Merry Christmas and Happy New Year from the team at Investing Women Angels ✨
The @BritishBBank Investment Fund for Scotland is now live - designed to support the growth of SME's across Scotland 👇
https://www.british-business-bank.co.uk/nations-and-regions-investment-funds/investment-fund-for-scotland-ifs/?dm_i=45HG,1KB3Y,3SHGNU,7BADG,1
;
